In general, through in vivo and in vitro experiments, we demonstrated that HBx could promote the proliferation of HCC cells, and reducing the expression of RSK2 can impair HBx-induced HCC proliferation. This evidence concerns the gene RPS6KA3 and hepatocellular carcinoma.